100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothEverolimus 0.25mg
You Searched
Suregraft 0.25 Tablet
Hospimax Healthcare Pvt. Ltd.
₹498
Our Recommendation
Advacan 0.25mg Tablet
356+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Prevention of organ rejection in transplant patients
Customers also bought
More About Suregraft
Benefits
In Prevention of organ rejection in transplant patients : Suregraft 0.25 Tablet is used with other medications to prevent organ transplant rejection. Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc. This medicine reduces the activity of a person's own immune system and prevents any such rejection.
Side Effects
Side effects of Suregraft Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Suregraft Infection Fever Cough Fatigue Diarrhea Upper respiratory tract infection
How to use
How to use Suregraft Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Suregraft 0.25 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
How Suregraft Tablet works Suregraft 0.25 Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Suregraft 0.25 Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Suregraft 0.25 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Suregraft 0.25 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Suregraft 0.25 Tablet may cause side effects which could affect your ability to drive.As fatigue is a common side effect with Suregraft 0.25 Tablet and this may affect your ability to drive
Suregraft 0.25 Tablet is safe to use in patients with kidney disease. No dose adjustment of Suregraft 0.25 Tablet is recommended.
Suregraft 0.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Suregraft 0.25 Tablet may be needed. Doctor consultation is advised.Use of Suregraft 0.25 Tablet is not recommended in patients with severe liver disease.
Manufacturer Address
109, First Floor, DDA Building No. 5 District Centre, Janakpuri New Delhi West Delhi DL 110058 IN
References
Krensky AM, Bennett WM, Vincenti F. Immunosuppressants, Tolerogens, and Immunostimulants. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1013
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 526
Everolimus. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2009 (06 Apr. 2019)
Everolimus. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2011 (22 Jan. 2019)
CiplaMed. Tacrolimus (20 Feb. 2024)
Everolimus (20 Feb. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
